Showing results (331-340 of 349) with videos related to
Sort By:
Pageof 35
Melanoma Research|January 30, 2025
A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockadeColin D Angell, Steven H Sun, Gabriella Lapurga, et al.Frontiers in Immunology|October 29, 2021
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With MelanomaSteven H Sun, Brooke Benner, Himanshu Savardekar, et al.Molecular Genetics & Genomic Medicine|January 24, 2015
The allelic spectrum of Charcot-Marie-Tooth disease in over 17,000 individuals with neuropathyChristina DiVincenzo, Christopher D Elzinga, Adam C Medeiros, et al.Scientific Reports|December 14, 2020
Soy-tomato enriched diet reduces inflammation and disease severity in a pre-clinical model of chronic pancreatitisDebasmita Mukherjee, Mallory J DiVincenzo, Molly Torok, et al.Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Mutant alcohol dehydrogenase leads to improved ethanol tolerance in Clostridium thermocellumSteven D Brown, Adam M Guss, Tatiana V Karpinets, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 28, 2022
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and EtoposideMartin Reck, Tony S K Mok, Aaron Mansfield, et al.Proceedings of the National Academy of Sciences of the United States of America|April 2, 2016
Engineering titania nanostructure to tune and improve its photocatalytic activityMatteo Cargnello, Tiziano Montini, Sergey Y Smolin, et al.Cancer Immunology, Immunotherapy : CII|August 1, 2023
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapySteven H Sun, Colin D Angell, Himanshu Savardekar, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2025
LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti-Programmed Cell Death Protein 1 or Anti-Programmed Cell Death Ligand 1 Plus Platinum ChemotherapyNatasha B Leighl, Luis Paz-Ares, Delvys Rodriguez Abreu, et al.Human Mutation|October 16, 2015
A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian DisordersIzabela Karbassi, Glenn A Maston, Angela Love, et al.Pageof 35